MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2024 International Congress » Epidemiology

Meeting: 2024 International Congress

12 year gap analysis in Parkinson’s Disease mortality in Brazil

L. Lobato, M F. Felippe, M. Fin, V. Souza, I. Fink, V. Muller, C. Rieder (Porto Alegre, Brazil)

Abstract: Trends in Movement Disorders related death in the United States from 1999 to 2020

A. Khalid, L. Munir, A. Chaudhary, M. Ammar-Ur-Rahman, A. Alabedi (Lahore, Pakistan)

Association between Dipeptidyl Peptidase-4 Inhibitor Usage and Mortality in Parkinson’s Disease: a nation-wide study

M. Park, K. Baik, I. Hong, M. Baek (Gwangmyeong, Republic of Korea)

Association between Non-Motor Parkinson’s disease symptoms and hyposmia in a population-based cohort

C. Theyer, K. Marini, F. Krismer, C. Horlings, H. Stockner, K. Schwarzová, I. Egner, A. Djamshidian-Tehrani, M. Marti, R. Krüger, V. Satagopam, B. Mollenhauer, S. Schade, C. Trenkwalder, K. Rege, S. Ghosh, A. Garrido, E. Tolosa, T. Marques, D. Mcintyre, W. Poewe, K. Seppi, P. Mahlknecht (Innsbruck, Austria)

Baseline NSD-ISS stage predicts long term progression and survival in sporadic PD: 10-year PPMI data analysis

P. Gonzalez-Latapi, C. Gochanour, H. Cho, S. Ho Choi, C. Caspell, C. Coffey, M. Brumm, Y. Xiao, DE. Lafontant, C. Venuto, C. Tanner, K. Kieburtz, L. Chahine, A. Siderowf, K. Marek, T. Simuni (Chicago, USA)

Changes in Parkinson’s Disease and Parkinsonian Syndromes A Comparative Retrospective Study in Kyrgyzstan

S. Medetbekova, B. Nurbekova (Bishkek, Kyrgyzstan)

Characteristics of Parkinson’s disease and associated healthcare resource utilization trends in a US all-payer health administrative claims database

W. Zhang, S. Shuvo, A. Gabriel, A. Yaldo, G. Agreda, C. Goetzsche, T. Machewitz, M. Nadimi, J. Lott (Whippany, USA)

Clinical and epidemiological profile of Parkinson’s disease in India

A. Kishore, R. Borgohain, KP. Divya, R. Rajan, P. Pal, H. Kumar, S. Mehta, N. Kumar, LK. Prashanth, S. Desai, R. Kandadai, R. Yadav, K. Shetty, P. Wadi, A. Aggarwal, P. Agarwal, M. Abbas, G. Wali, T. Ferreira, A. Srivastava, N. Kamble, M. Divya, S. Krishnan, L. Gonzalez-Ricardo, M. Chacko, M. Sharma (Kochi, India)

Clinical characteristics of movement disorders associated with multiple sclerosis patients: A cross sectional preliminary single center results.

MM. Meshref, AF. El-Adawy, FM. Mansour, MH. Moawad, MEL. Elmasry, HG. Gad (Cairo, Egypt)

Clinical profile of early-onset Parkinson’s disease

S. Peña Martinez, R. Ayala Minero, R. Amaya, A. Medina Escobar, P. Salles (San Salvador, El Salvador)

Cohort effects on risk scores and risk markers for Parkinson’s disease – comparison of an online-recruited versus population-based cohort

K. Marini, C. Theyer, C. Horlings, H. Stockner, K. Schwarzová, I. Egner, A. Djamshidian-Tehrani, G. Rungger, P. Willeit, J. Willeit, S. Kiechl, M. Martì, A. Garrido, E. Tolosa, B. Mollenhauer, C. Trenkwalder, S. Schade, R. Krüger, V. Satagopam, K. Rege, S. Ghosh, T. Marques, D. Mcintyre, K. Seppi, W. Poewe, P. Mahlknecht (Innsbruck, Austria)

Disparities in Botulinum Toxin Utilization for Cervical Dystonia in a United States Medicare Population

M. Verduzco-Gutierrez, A. Keener, I. Howard, D. Torres-Russotto, J. Sparrow, R. Kazerooni (San Antonio, USA)

Environmental Factors are Associated with Disease Severity of LRRK2 Related Parkinson’s Disease and Idiopathic Parkinson’s Disease: a Longitudinal Study

T. Lüth, A. Caliebe, C. Gabbert, S. Koch, B-H. Laabs, IR. König, C. Klein, J. Trinh (Lübeck, Germany)

Exploratory Cross-Sectional Analysis of Lifestyle and Parkinson’s Disease Symptomatology

O. Di Martino, N. Meier, S. Shafer, B. Stewart-Burger (Irvine, USA)

Gender Differences in Physical Activity in Parkinson’s Disease

G. Vitek, M. Fullard (Aurora, USA)

Global Trend of Parkinson’s Disease in 38 OECD Countries from 1990-2019: An Insight from the GBD 2019.

H. Desai, H. Chhayani, N. Brahmbhatt, J. Jobby, B. Desai, M. Lakkimsetti, P. Vemparala (Bhuj, India)

Incidence and Prevalence of Parkinson’s Disease Among United States Medicare Beneficiaries by Age, Sex, Race/Ethnicity, and Neighborhood Socioeconomic Status 2014-2021

T. Rosa, S. Mantri, C. Ford, S. Soneji, B. Kaufman, F. Li, B. Grory, Y. Xian, K. Johnson, R. O’Brien, E. O’Brien, J. Lusk, B. Hammill (Durham, USA)

Long-term Blood Pressure Measures in Incident Parkinson’s Disease in the Framingham Heart Study.

S. O'Shea, Y. Liu, Y. Li, A. Gurnani, J. Dookhy, S. Frank, R. Au, J. Mez, T. Ang, L. Shih (New York, USA)

Motor and Non-Motor Characteristics of Parkinson’s Disease in a Prevalent Population in Tanzania

R. Morton, O. Williams, J. Josephat, M. Dekker, W. Howlett, E. Assey, N. Fothergill-Misbah, C. Dotchin, S. Urasa, R. Walker (North Shields, United Kingdom)

No Association between Anemia and Risk of Parkinson’s Disease: Evidence From A Meta-Analysis Using Real-World Evidence

S. Zayed, S. Tabassum (Ranchi, India)

Non-Motor Symptoms and Comorbidities in a Cohort of Puerto Rican Parkinson’s Disease: Do They Affect Severity and Progression?

C. Serrano, K. Palermo, M. Morales, V. Wojna (San Juan, Puerto Rico)

Parkinson’s Disease Burden in Underserved Populations Across the US in 2022

S. Kowal, K. Rosettie, E. Mearns, N. Win, H. Lin, B. Musch (South San Francisco, USA)

Parkinson’s disease in Brazil: prevalence and patient characteristics in a nationwide representative population-based cohort.

D. Teixeira-Dos-Santos, G. Magalhães Pereira, G. Alves Marconi, T. Hugentobler Schlickmann, AF. Schumacher Schuh (Porto Alegre, Brazil)

PD in Tanzania: representative in city dwellers, absent in nomadic tribespeople?

S. Urasa, W. Howlett, R. Walker, M. Dekker (Moshi, United Republic of Tanzania)

Predicting the Risk of Parkinson’s Disease by Body Composition and Metabolic Diseases in Gender and Age Dependent Manners

J. Fu, H. Shang, X. Chen (Chengdu, Sichuan, China)

Prevalence and Spectrum of Movement Disorders in a Rural Neurology Clinic in Western India

D. Desai, S. Udani, A. Shah, S. Desai (Anand, India)

Prevalence of Advanced Parkinson’s Disease and Potential Candidacy for Device-Aided Therapies in the Casablanca Region: Preliminary Results of a Multicenter Regional Study

M. Daghi, A. Lakhdar, H. El Otmani (Casablanca, Morocco)

Prevalence of Cognitive Disorders and Other Features of Parkinson’s Disease in Kyrgyz Republic

E. Eralieva, M. Moldokulova, K. Dzholboldieva (Osh, Kyrgyzstan)

Prevalence of Tic Disorder in School Children of Northern India

S. Lavania, A. Pattojoshi, AH. Khan (Agra, India)

PREVENT-PD: A Framework for Collecting Trichloroethylene Contamination Data in New York State

M. Pawlik, K. Hylton, S. Hussain, M. Piraino, D. Kinel, R. Dorsey (Rochester, USA)

Prodromal and overt Parkinson’s Disease Epidemiological Study in Brazil (PROBE-PD study): preliminary results

L. Pedrosa, J. Duarte, G. Pereira, I. Oliveira, S. Titze-de-Almeida, A. Schuh, C. Rieder, G. Valença, P. Brandão, L. Krejcová, B. Santos-Lobato (Belém, Brazil)

Profile of patients affected by movement disorders in subspecialized outpatient clinics of a tertiary hospital in Southern Brazil

D. Teixeira-Dos-Santos, G. Magalhães Pereira, T. de Carvalho, P. Ribeiro Rigo, J. Käfer Pasin, I. Fonseca Benati, E. Drews Amorim, M. Testa-da-Silva, T. Lampert Monte, BS. de Oliveira, R. Machado Castilhos, AF. Schumacher Schuh (Porto Alegre, Brazil)

Prognostic Value of Parkinson’s Disease Subtypes in the LABS-PD Cohort: Functional ability, Quality of life and Mortality

D. Dash, S. Eberly, D. Oakes, D. Grimes, A. Lang, C. Tanner, C. Marras, T. Mestre (Ottawa, Canada)

Rural Tanzania’s Wide “PD Gap” Through the Decades

M. Dekker, S. Urasa, W. Howlett, R. Morton, J. Josephat, R. Walker (Moshi, United Republic of Tanzania)

Spectrum of Movement Disorders in Kazakhstan: Five Years of Insights from Kazakhstan’s First Movement Disorder Center

ZH. Myrzayev, CH. Shashkin, G. Seidakhmetova, B. Abdenov, R. Kaiyrzhanov (Almaty, Kazakhstan)

Systematic Review and Meta-Analysis of Pesticide Exposure and the Risk of Parkinson’s Disease

J. Cheong, ZHK. Goh, H. Frankland, S. Spearman, J. Steinmetz, A. Noyce (London, United Kingdom)

Systematic Review of Incidence and Prevalence Studies of Multiple System Atrophy

B. Benzahia, E. Carter, D. Swallow (Aberdeen, United Kingdom)

Trend-Analysis of Movement Disorders, Malignant Neoplasms and Mortality from 1999-2020

M. Ammar-Ur-Rahman, L. Munir, A. Khalid, A. Chaudhary (Lahore, Pakistan)

Validation of PD Ascertainment in the VA Electronic Medical Record (EMR)

S. Goldman, F. Weaver, L. Cao, S. Jugnundan, B. Gonzalez, K. Stroupe, K. Colletta, E. Brown, C. Tanner (San Francisco, USA)

« View all sessions from the 2024 International Congress.

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley